S&P 500 stocks beyond the realm of AI are on pace for their second-largest weekly outperformance since 2024.
Non-AI Stocks Lead Market Outperformance This week, stocks that are not directly involved in the artificial intelligence sector have demonstrated a significant outperformance over the broader market, marking one of the widest margins recorded in nearly three years, according to a comprehensive analysis by CNBC using FactSet data. The S&P ex-AI index notably gained 2.4% through Thursday, in stark contrast to the S&P 500 index which experienced a decline of almost 1%. This translates to an impressive 3.29 percentage-point outperformance for non-AI stocks, positioning it as the second-biggest weekly outperformance since early 2024. The only other period with a more substantial divergence was the week ending June 26, when non-AI stocks climbed 2.3% while the S&P 500 dropped approximately 2%, resulting in a 4.26 percentage-point spread. This trend suggests a potential shift in investor focus beyond the dominant AI narrative, with investors increasingly reassessing a market heavily influenced by a concentrated group of AI-related companies since ChatGPT's debut in late 2022. Prominent Non-AI Companies Driving Gains A closer look at the S&P 500 reveals several companies not directly linked to artificial intelligence that have significantly contributed to this week's market rally. Among the top performers are Fair Isaac, which saw an impressive increase of almost 14%; Equifax, surging ahead by 10.4%; Darden Restaurants, climbing 10.3%; and Brown-Forman, which posted a strong gain of 9%. This diverse group of companies, spanning various sectors, underscores that market vitality is not exclusively confined to AI-driven enterprises. Their strong performance indicates a broadening of investment opportunities and a healthy reassessment of market drivers, suggesting that gains are extending beyond the companies primarily associated with the current AI hype. The Strategic Role of the S&P ex-AI Index Recognizing the market's increasing concentration around a select few AI-related companies, Goldman Sachs and S&P Dow Jones Indices introduced the S&P ex-AI index (ticker: SPXXAI) in February. This innovative index serves as a crucial tool for investors, allowing them to measure performance or implement hedging strategies specifically against the AI trade. It is designed to exclude companies with substantial exposure to AI-related revenues, infrastructure, or demand, including those involved in chips, data centers, networking, and cloud computing. At its inception, AI-related companies constituted approximately 45% of the S&P 500, highlighting the index's relevance in providing a clearer picture of market dynamics beyond the AI sector. The index's historical data was back-tested to early January 2024 to provide a robust benchmark for analyzing non-AI market trends. Exploring "Non-Tech Compounders" for Portfolio Diversification In light of the recent market shifts, research firms such as Trivector Research are actively exploring and advocating for "non-tech compounders." These are defined as companies capable of delivering rapid growth without being dependent on the massive capital expenditures or rapid development cycles characteristic of the AI buildout. Notable examples identified in this category include pharmaceutical giant Eli Lilly, luxury accessories company Tapestry, and biopharmaceutical firm AbbVie. Adam Parker, the founder of Trivector, emphasizes the critical role these non-tech compounders can play in diversifying investment portfolios. He suggests they offer a valuable defensive and growth-oriented component, especially if the leadership in the AI market begins to decentralize or if overall market volatility intensifies. This strategic avenue allows investors to find sustained returns in a broader range of companies.
Non-AI Stocks Lead Market Outperformance
This week, stocks that are not directly involved in the artificial intelligence sector have demonstrated a significant outperformance over the broader market, marking one of the widest margins recorded in nearly three years, according to a comprehensive analysis by CNBC using FactSet data. The S&P ex-AI index notably gained 2.4% through Thursday, in stark contrast to the S&P 500 index which experienced a decline of almost 1%. This translates to an impressive 3.29 percentage-point outperformance for non-AI stocks, positioning it as the second-biggest weekly outperformance since early 2024. The only other period with a more substantial divergence was the week ending June 26, when non-AI stocks climbed 2.3% while the S&P 500 dropped approximately 2%, resulting in a 4.26 percentage-point spread. This trend suggests a potential shift in investor focus beyond the dominant AI narrative, with investors increasingly reassessing a market heavily influenced by a concentrated group of AI-related companies since ChatGPT's debut in late 2022.
Prominent Non-AI Companies Driving Gains
A closer look at the S&P 500 reveals several companies not directly linked to artificial intelligence that have significantly contributed to this week's market rally. Among the top performers are Fair Isaac, which saw an impressive increase of almost 14%; Equifax, surging ahead by 10.4%; Darden Restaurants, climbing 10.3%; and Brown-Forman, which posted a strong gain of 9%. This diverse group of companies, spanning various sectors, underscores that market vitality is not exclusively confined to AI-driven enterprises. Their strong performance indicates a broadening of investment opportunities and a healthy reassessment of market drivers, suggesting that gains are extending beyond the companies primarily associated with the current AI hype.
The Strategic Role of the S&P ex-AI Index
Recognizing the market's increasing concentration around a select few AI-related companies, Goldman Sachs and S&P Dow Jones Indices introduced the S&P ex-AI index (ticker: SPXXAI) in February. This innovative index serves as a crucial tool for investors, allowing them to measure performance or implement hedging strategies specifically against the AI trade. It is designed to exclude companies with substantial exposure to AI-related revenues, infrastructure, or demand, including those involved in chips, data centers, networking, and cloud computing. At its inception, AI-related companies constituted approximately 45% of the S&P 500, highlighting the index's relevance in providing a clearer picture of market dynamics beyond the AI sector. The index's historical data was back-tested to early January 2024 to provide a robust benchmark for analyzing non-AI market trends.
Exploring "Non-Tech Compounders" for Portfolio Diversification
In light of the recent market shifts, research firms such as Trivector Research are actively exploring and advocating for "non-tech compounders." These are defined as companies capable of delivering rapid growth without being dependent on the massive capital expenditures or rapid development cycles characteristic of the AI buildout. Notable examples identified in this category include pharmaceutical giant Eli Lilly, luxury accessories company Tapestry, and biopharmaceutical firm AbbVie. Adam Parker, the founder of Trivector, emphasizes the critical role these non-tech compounders can play in diversifying investment portfolios. He suggests they offer a valuable defensive and growth-oriented component, especially if the leadership in the AI market begins to decentralize or if overall market volatility intensifies. This strategic avenue allows investors to find sustained returns in a broader range of companies.
